symptoms of melanoma bone metastasis

Written by Sun Ming Yue

Medical Oncology

Updated on September 01, 2024

00:00

00:00

Once melanoma metastasizes, patients will experience significant pain, which will become increasingly severe and eventually unbearable. Having melanoma can also cause the bones to become brittle and prone to fractures and cracks. Once melanoma metastasizes, it also destroys the body's immune system, causing patients to suffer from long-term headaches and nausea, and making the body weaker.

Other Voices

home-news-image

Written by Cui Fang Bo

Oncology

36sec

home-news-image

Stage IV melanoma is what stage?

Melanoma stage IV is stage 4, where IV is the Roman numeral for 4. Stage IV melanoma means that the melanoma is no longer confined to the site of origin and has metastasized to distant organs. Melanoma commonly originates in the skin and mucous membranes, with the most common sites of metastasis being the lymph nodes and lungs. Once melanoma reaches stage 4, the opportunity for curative surgery is lost. Treatment primarily involves immunotherapy, targeted molecular therapy, etc., and is incurable.

home-news-image

Written by Huang Ling Juan

Dermatology

1min 6sec

home-news-image

Can a melanoma heal by itself if it ruptures?

Melanoma cannot heal itself once it has ruptured. Melanoma is a type of malignant tumor, and if melanoma occurs, it is crucial to cooperate actively with the doctor to perform excision surgery. After the surgical removal, pathological examination must be carried out, and treatment should be sought promptly to avoid delaying the condition. If there is bleeding, ulceration, pain, or a significant increase in the size of skin pigmented moles, it is highly suspect for malignant transformation, and one should promptly visit a dermatology department at a formal hospital for examination. If malignant transformation is possible, it is critical to perform surgery early and conduct a pathological examination. The symptoms of melanoma are related to the age of onset; in younger patients, it usually presents as itching, changes in the color of the lesions, and expanding borders, while older patients typically exhibit noticeable ulceration of the lesions.

home-news-image

Written by Cui Fang Bo

Oncology

50sec

home-news-image

Can melanoma be cured if it is excised early?

For patients with early-stage melanoma, if complete excision is achieved after surgical removal, some patients can be cured. Melanoma originates from melanocytes, which are malignant tumors. Melanocytes are distributed throughout the body, hence melanoma can occur in multiple parts of the body, primarily in the skin and mucous membranes, accounting for about 70% of cases. For early-stage melanoma, the main treatment method is still surgical excision. For patients with deeper melanoma infiltration, regional lymph node dissection is also necessary. After radical excision, treatments such as immunotherapy can be administered to consolidate the effects of the therapy, and some of the patients who complete these treatments can be cured.

home-news-image

Written by Cui Fang Bo

Oncology

47sec

home-news-image

Can melanoma without metastasis avoid chemotherapy?

For patients with melanoma that has not metastasized, direct surgical removal can be performed, and chemotherapy is not necessary after surgery. Melanoma is a malignant tumor that originates from melanocytes and can occur in many parts of the body, with melanomas of the skin and mucous membranes being the most common, accounting for about 70% of all cases. Once melanoma is diagnosed, if there is no distant metastasis to other organs, curative surgical removal can be performed. Postoperative treatment mainly involves immunotherapy, not systemic chemotherapy. For patients who are diagnosed with distant organ metastasis, systemic chemotherapy and immunotherapy are required.

home-news-image

Written by Yan Chun

Oncology

48sec

home-news-image

Is it better for melanoma to have a BRAF mutation or not to have a BRAF mutation?

Melanoma is a type of skin cancer with a very high malignancy. Before targeted drugs were available, patients with BRAF gene mutations indicated a poorer prognosis for melanoma. The mutation of the BRAF gene promotes the progression of melanoma. However, with the advancement of current clinical research, patients with melanoma having BRAF mutations have a better therapeutic effect with BRAF inhibitor targeted therapy. After adopting this targeted drug treatment, the cure rate has significantly increased, and the prognosis of patients has markedly improved. Therefore, patients with BRAF-mutated melanoma can benefit from targeted therapy.